5 Medicines for humans for the treatment of cardiovascular diseases, metabolic diseases, liver diseases, and genetic disorders; pharmaceutical preparations for the treatment of cardiovascular diseases, metabolic diseases, liver diseases, and genetic disorders; chemico-pharmaceutical preparations for the treatment of cardiovascular diseases, metabolic diseases, liver diseases, and genetic disorders; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of cardiovascular diseases, metabolic diseases, liver diseases, and genetic disorders; biological preparations for medical purposes for the treatment of cardiovascular diseases, metabolic diseases, liver diseases, and genetic disorders; chemical preparations for pharmaceutical purposes for the treatment of cardiovascular diseases, metabolic diseases, liver diseases, and genetic disorders; chemical preparations for medical purposes for the treatment of cardiovascular diseases, metabolic diseases, liver diseases, and genetic disorders; crude drugs being pharmaceutical preparations for the treatment of cardiovascular diseases, metabolic diseases, liver diseases, and genetic disorders; pharmaceuticals for the treatment of cancer; pharmaceuticals for the treatment of infectious diseases; diagnostic preparations for medical purposes; dietetic substances adapted for medical use, namely, dietary supplements and dietetic foods adapted for medical use; depuratives for the body; pharmaceutical preparations for the treatment of hypercholesteremia; pesticides; pharmaceutical preparations for the treatment of hyperlipidemia; pharmaceutical preparations for treating diabetes; pharmaceutical agents affecting metabolism; anticoagulants; medicines for veterinary purposes for the treatment of gastrointestinal diseases and condition; cardiovascular pharmaceuticals; pharmaceutical preparations for ocular or intraocular surgery; dressings, medical; composite materials for dental purposes; diapers for pets